FDA Approved: DEFERASIROX — Original Application (Xiromed, LLC)

View source ↗

Summary

FDA approved Xiromed, LLC's generic deferasirox (DEFERASIROX) through an original ANDA.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Beta Thalassemia Major
• Myelodysplastic Syndrome
• Sickle Cell Disease
• Transfusion-dependent Iron Overload

Drugs mentioned

• Deferasirox (Deferasirox)

Snippet

ORIG AP for DEFERASIROX (DEFERASIROX)